BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36119471)

  • 1. Potentially functional variants of
    Huang Q; Liu Y; Qiu M; Lin Q; Wei X; Zhou Z; Liang X; Li R; Chen W; Zhou X; Yu H
    Front Oncol; 2022; 12():990160. PubMed ID: 36119471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between genetic variants in sphingolipid metabolism pathway genes and hepatitis B virus-related hepatocellular carcinoma survival.
    Jiang B; Qiu M; Qin L; Tang J; Zhan S; Lin Q; Wei J; Liu Y; Zhou Z; Liang X; Cao J; Lian J; Mai Y; Jiang Y; Yu H
    Front Oncol; 2023; 13():1252158. PubMed ID: 38260847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants of SOS2, MAP2K1 and RASGRF2 in the RAS pathway genes predict survival of HBV-related hepatocellular carcinoma patients.
    Lin Q; Qiu M; Wei X; Xiang Z; Zhou Z; Ji I; Liang X; Zhou X; Wen Q; Liu Y; Yu H
    Arch Toxicol; 2023 Jun; 97(6):1599-1611. PubMed ID: 37029817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between novel genetic variants of Notch signaling pathway genes and survival of hepatitis B virus-related hepatocellular carcinoma.
    Qin L; Qiu M; Lin Q; Jiang B; Zhan S; Wei X; Wei J; Liu Y; Wen Q; Chen P; Jiang Y; Zhou Z; Liang X; Cao J; Gong Y; Wei Y; Wei X; Yu H
    Cancer Med; 2024 Apr; 13(7):e7040. PubMed ID: 38562021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentially functional genetic variants in RPS6KA4 and MAP2K5 in the MAPK signaling pathway predict HBV-related hepatocellular carcinoma survival.
    Qiu M; Lin Q; Liu Y; Chen P; Zhou Y; Jiang Y; Zhou Z; Wen Q; Zhou X; Liang X; Gan H; Yu H
    Mol Carcinog; 2023 Sep; 62(9):1378-1387. PubMed ID: 37278562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentially Functional Genetic Variants in the NRF2 Signaling Pathway Genes are Associated With HBV-related Hepatocellular Carcinoma Survival.
    Gong R; Qiu M; Cao J; Zhou Z; Wei Y; Wen Q; Lin Q; Wei X; Liang X; Jiang Y; Chen P; Wei J; Zhan S; Liu Y; Yu H
    J Cancer; 2023; 14(18):3387-3396. PubMed ID: 38021150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentially functional genetic variants in ferroptosis-related CREB3 and GALNT14 genes predict survival of hepatitis B virus-related hepatocellular carcinoma.
    Zhan S; Qiu M; Wei X; Wei J; Qin L; Jiang B; Wen Q; Chen P; Lin Q; Wei X; Zhou Z; Jiang Y; Liang X; Li R; Liu Y; Yu H
    Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38151984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma.
    Yu T; Han C; Zhu G; Liao X; Qin W; Yang C; Liu Z; Su H; Liu X; Yu L; Liu Z; Lu S; Chen Z; Liang Y; Huang J; Qin X; Gui Y; Li J; Peng T
    Cancer Med; 2017 Jul; 6(7):1587-1600. PubMed ID: 28568708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Role of MAP3K14 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis and Validation.
    Tang K; Lin W; Wang D; Hu X; Chen Z; Chen J; Liang B; Zhang L; Qin P; Wu D
    J Cancer; 2024; 15(9):2731-2745. PubMed ID: 38577603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma.
    Zhang Q; Ji XW; Hou XM; Lu FM; Du Y; Yin JH; Sun XY; Deng Y; Zhao J; Han X; Yang GS; Zhang HW; Chen XM; Shen HB; Wang HY; Cao GW
    Ann Oncol; 2014 Dec; 25(12):2413-2419. PubMed ID: 25223483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants in m5C modification genes are associated with survival of patients with HBV-related hepatocellular carcinoma.
    Chen B; Qiu M; Gong R; Liu Y; Zhou Z; Wen Q; Wei X; Liang X; Jiang Y; Chen P; Wei Y; Huang Q; Mo Q; Lin Q; Yu H
    Arch Toxicol; 2024 Apr; 98(4):1125-1134. PubMed ID: 38438738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome-wide association study for persistent hepatitis B virus infection and related hepatocellular carcinoma.
    Han J; Chen C; Wang C; Qin N; Huang M; Ma Z; Zhu M; Dai J; Jiang Y; Ma H; Jin G; Shen H; Hu Z
    Liver Int; 2020 Sep; 40(9):2117-2127. PubMed ID: 32574393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma.
    Liu Z; Song C; Wen J; Xu L; Liu Y; Zhu J; Zhu L; Hu Z; Ma H; Liu L
    Oncotarget; 2016 Jul; 7(28):44076-44083. PubMed ID: 27286450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of HLA-DQB1 predict survival of hepatitis B virus-related hepatocellular carcinoma patients receiving hepatic resection.
    Liu X; Yu L; Han C; Lu S; Zhu G; Su H; Qin W; Liao X; Peng T
    Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):739-747. PubMed ID: 27288300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATXN7 Gene Variants and Expression Predict Post-Operative Clinical Outcomes in Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Han C; Yu L; Liu X; Yu T; Qin W; Liao X; Liu Z; Lu S; Chen Z; Su H; Zhu G; Qin X; Gui Y; Li J; Xiao K; Chen X; Ye X; Peng M; Dong J; Peng T
    Cell Physiol Biochem; 2016; 39(6):2427-2438. PubMed ID: 27855399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants of cell cycle pathway genes predict disease-free survival of hepatocellular carcinoma.
    Liu S; Yang TB; Nan YL; Li AH; Pan DX; Xu Y; Li S; Li T; Zeng XY; Qiu XQ
    Cancer Med; 2017 Jul; 6(7):1512-1522. PubMed ID: 28639733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of integrin variants and expression in post-operative patients with HBV-related hepatocellular carcinoma.
    Shang L; Ye X; Zhu G; Su H; Su Z; Chen B; Xiao K; Li L; Peng M; Peng T
    Oncotarget; 2017 Sep; 8(44):76816-76831. PubMed ID: 29100351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants and Expression of Cytochrome p450 Oxidoreductase Predict Postoperative Survival in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Huang K; Liao X; Han C; Wang X; Yu T; Yang C; Liu X; Yu L; Chen Z; Qin W; Zhu G; Su H; Liu Z; Zeng X; Zhou X; Lu S; Huang J; Liang Y; Liu Z; Deng J; Ye X; Peng T
    J Cancer; 2019; 10(6):1453-1465. PubMed ID: 31031855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Genetic Variant of PPP1CB Influences Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Chinese: A Pathway Based Analysis.
    Mai H; Xie H; Hou J; Chen H; Zhou B; Hou J; Jiang D
    J Hepatocell Carcinoma; 2021; 8():1055-1064. PubMed ID: 34513747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.